Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Clinical Study of the Value of Circulating Free Methylated EBV DNA in Extranodal NK/T Cell Lymphoma
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Summary
This study is a prospective, multicenter, open-label, single-arm clinical study. This study plans to enroll 72 newly diagnosed ENKTCL patients. The enrollment was completed in 2 years, and the follow-up was terminated in 4 years. To observe the accuracy of circulating free methylated EBV DNA in predicting 2-year PFS rate, 2-year OS rate, and CR rate in newly diagnosed ENKTCL patients; and to clarify the prognostic stratification ability of PINK-cpgE compared with PINK-E
Official title: Prospective, Multicenter Clinical Study of Accurate Stratification and Prognostic Value of Circulating Free Methylated EBV DNA in Extranodal NK/T Cell Lymphoma
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
72
Start Date
2022-06-01
Completion Date
2028-06-01
Last Updated
2022-04-25
Healthy Volunteers
No
Interventions
circulate free methylated EBV DNA
Accuracy of circulating free methylated EBV DNA in predicting 2-year PFS
Locations (1)
The First Affiliated Hospital of Nanjing Medical University
Nanjing, China